299
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

Ofatumumab for the treatment of chronic lymphocytic leukemia

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Omid Rezahosseini, Sara Hanaei, Mehdi Hamadani, Mahsa Keshavarz-Fathi & Nima Rezaei. (2018) The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma. International Reviews of Immunology 37:3, pages 165-173.
Read now
Peter H. Wiernik. (2016) Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia. Expert Opinion on Investigational Drugs 25:6, pages 729-734.
Read now

Articles from other publishers (3)

Josselin Bernard, Fanny Lalieve, Julie Sarlat, Justine Perrin, Laurene Dehoux, Olivia Boyer, Astrid Godron-Dubrasquet, Jerome Harambat, Stephane Decramer, Mathilde Caillez, Alexandra Bruel, Emma Allain-Launay, Jacques Dantal & Gwenaëlle Roussey. (2020) Ofatumumab treatment for nephrotic syndrome recurrence after pediatric renal transplantation. Pediatric Nephrology 35:8, pages 1499-1506.
Crossref
Eduardo Mansilla, Luis Nunez, Gustavo H. Marin, Luis Rivera, Paolo Macor & Sandra Pena Luengas. 2019. Biomedical Applications of Nanoparticles. Biomedical Applications of Nanoparticles 409 430 .
Anthony Mato, Chadi Nabhan, Neil E. Kay, Mark A. Weiss, Nicole Lamanna, Thomas J. Kipps, David L. Grinblatt, Ian W. Flinn, Mark F. Kozloff, Christopher R. Flowers, Charles M. Farber, Pavel Kiselev, Arlene S. Swern, Kristen Sullivan, E. Dawn Flick & Jeff P. Sharman. (2016) Real‐world clinical experience in the Connect ® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres . British Journal of Haematology 175:5, pages 892-903.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.